Monika Ermann

Targeting deubiquitinase activity with a novel small-molecule inhibitor as therapy for B-cell malignancies

Luke F. Peterson, Hanshi Sun, Yi‐Hong Liu et al. · Blood · 2015 · 125 citations · Full text

Medicine, Medicinal Chemistry, Oncology +11

Structure-Based Design of Novel 2-Amino-6-phenyl-pyrimido[5′,4′:5,6]pyrimido[1,2-<i>a</i>]benzimidazol-5(6<i>H</i>)-ones as Potent and Orally Active Inhibitors of Lymphocyte Specific Kinase (Lck): Synthesis, SAR, and In Vivo Anti-Inflammatory Activity

Matthew W. Martin, John Newcomb, Joseph J. Nunes et al. · Journal of Medicinal Chemistry · 2008 · 64 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Novel 2-Aminopyrimidine Carbamates as Potent and Orally Active Inhibitors of Lck:  Synthesis, SAR, and in Vivo Antiinflammatory Activity

Matthew W. Martin, John Newcomb, Joseph J. Nunes et al. · Journal of Medicinal Chemistry · 2006 · 61 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Arylsulfonamide CB2 receptor agonists: SAR and optimization of CB2 selectivity

Monika Ermann, Doris Riether, Edward R. Walker et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 30 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Some regioselective cross-coupling reactions of halopyridines and halopyrimidines

Nadja M. Simkovsky, Monika Ermann, Stanley M. Roberts et al. · Journal of the Chemical Society Perkin Transactions 1 · 2002 · 26 citations

Natural Sciences, Chemistry, Medicinal Chemistry +7